Extensions

Patent Term and Application History for US10430725B2

As of May 1, 2026, the following information has been compiled for U.S. Patent No. 10,430,725 B2 based on a review of United States Patent and Trademark Office (USPTO) records.

Patent Term Adjustments (PTA) and Extensions (PTE)

• Patent Term Adjustment (PTA): There is no publicly recorded Patent Term Adjustment for US10430725B2. The patent's term is calculated from its filing date without modification for USPTO processing delays.
• Patent Term Extension (PTE): There is no record of a Patent Term Extension for US10430725B2. PTE is typically granted for patents covering products that undergo a lengthy regulatory review process (e.g., pharmaceuticals), which is not applicable here.

Application History and Related Family Members

• Application Number: The patent was granted from U.S. patent application number 15/409,425.
• Filing Date: The application was filed on January 18, 2017.
• Priority Information: This application claims priority to U.S. Provisional Patent Application No. 62/350,663, filed on June 15, 2016.
• Continuations/Divisionals: The prosecution history of this patent led to subsequent related applications:
  • Continuation: U.S. Patent Application No. 16/538,189 (now U.S. Patent No. 10,699,218) was filed as a continuation.
  • Continuation: U.S. Patent Application No. 16/916,013 (now U.S. Patent No. 11,074,522) was also filed as a continuation.
    These related patents form part of the same patent family and share the same priority date and core specification.
• Patent Family: Beyond the direct continuations, the patent family includes the original publication of the application as US20170364795A1.

Projected Expiration Date

The term of a U.S. patent is generally 20 years from the filing date of the earliest U.S. or international (PCT) application to which priority is claimed.

• Earliest Priority Date: January 18, 2017 (based on the filing of application 15/409,425).
• Standard 20-Year Term: A 20-year term from this filing date would normally end on January 18, 2037.

However, public patent databases indicate an adjusted expiration date of May 13, 2038. This discrepancy suggests a potential Patent Term Adjustment may have been granted that is not immediately apparent in the basic bibliographic data, or there may be other factors influencing the term calculation. The USPTO provides the final determination of a patent's term. Absent an official PTA calculation from the USPTO, the standard expiration would be January 18, 2037, but the publicly listed adjusted date should be noted.